Selheim F - Search Results

1

Rethinking the role of osteopontin in human acute myeloid leukemia.

Brenner AK, Aasebø E, Hernandez-Valladares M, Selheim F, Berven F, Bruserud Ø. Brenner AK, et al. Among authors: selheim f. Leuk Lymphoma. 2017 Jun;58(6):1494-1497. doi: 10.1080/10428194.2016.1243682. Epub 2016 Oct 14. Leuk Lymphoma. 2017. PMID: 27739925 No abstract available.

2

Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells.

Oveland E, Gjertsen BT, Wergeland L, Selheim F, Fladmark KE, Hovland R. Oveland E, et al. Among authors: selheim f. Leuk Res. 2009 Feb;33(2):276-87. doi: 10.1016/j.leukres.2008.06.029. Epub 2008 Aug 8. Leuk Res. 2009. PMID: 18691757

3

Minimization of side reactions during Lys Tag derivatization of C-terminal lysine peptides.

Mjaavatten O, Nygaard G, Berven FS, Selheim F. Mjaavatten O, et al. Among authors: selheim f. Anal Chim Acta. 2012 Jan 27;712:101-7. doi: 10.1016/j.aca.2011.11.017. Epub 2011 Nov 19. Anal Chim Acta. 2012. PMID: 22177071

4

Iodinin (1,6-dihydroxyphenazine 5,10-dioxide) from Streptosporangium sp. induces apoptosis selectively in myeloid leukemia cell lines and patient cells.

Myhren LE, Nygaard G, Gausdal G, Sletta H, Teigen K, Degnes KF, Zahlsen K, Brunsvik A, Bruserud Ø, Døskeland SO, Selheim F, Herfindal L. Myhren LE, et al. Among authors: selheim f. Mar Drugs. 2013 Jan 30;11(2):332-49. doi: 10.3390/md11020332. Mar Drugs. 2013. PMID: 23364682 Free PMC article.

5

Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines.

Aasebø E, Vaudel M, Mjaavatten O, Gausdal G, Van der Burgh A, Gjertsen BT, Døskeland SO, Bruserud O, Berven FS, Selheim F. Aasebø E, et al. Among authors: selheim f. Proteomics. 2014 Sep;14(17-18):1971-6. doi: 10.1002/pmic.201300448. Epub 2014 Aug 8. Proteomics. 2014. PMID: 25044641

6

Practical Considerations for Omics Experiments in Biomedical Sciences.

Vaudel M, Barsnes H, Bjerkvig R, Bikfalvi A, Selheim F, Berven FS, Daubon T. Vaudel M, et al. Among authors: selheim f. Curr Pharm Biotechnol. 2016;17(1):105-14. doi: 10.2174/1389201016666150817095348. Curr Pharm Biotechnol. 2016. PMID: 26278526 Review.

7

Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients.

Aasebø E, Forthun RB, Berven F, Selheim F, Hernandez-Valladares M. Aasebø E, et al. Among authors: selheim f. Curr Pharm Biotechnol. 2016;17(1):52-70. doi: 10.2174/1389201016666150826115626. Curr Pharm Biotechnol. 2016. PMID: 26306748 Free PMC article. Review.

8

Editorial: Toward Personalized Treatment for Acute Myeloid Leukemia.

Selheim F, Herfindal L. Selheim F, et al. Curr Pharm Biotechnol. 2016;17(1):4-5. doi: 10.2174/138920101701151027165031. Curr Pharm Biotechnol. 2016. PMID: 26311133 No abstract available.

9

The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia.

Forthun RB, Hinrichs C, Dowling TH, Bruserud Ø, Selheim F. Forthun RB, et al. Among authors: selheim f. Curr Pharm Biotechnol. 2016;17(1):6-19. doi: 10.2174/1389201016666150907113653. Curr Pharm Biotechnol. 2016. PMID: 26343130 Review.

10

Interpretation of Quantitative Shotgun Proteomic Data.

Aasebø E, Berven FS, Selheim F, Barsnes H, Vaudel M. Aasebø E, et al. Among authors: selheim f. Methods Mol Biol. 2016;1394:261-273. doi: 10.1007/978-1-4939-3341-9_19. Methods Mol Biol. 2016. PMID: 26700055

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters